// App-Quantinova.ai

: Relative pulmonary bioavailability (BA) of fluticasone propionate/formoterol (FP/FORM) via pressurised metered-dose inhaler (pMDI) and a novel breath-triggered inhaler (BTI)

Researchers

Presenter

  • David Bell

Principal Investigators

  • Gill Mundin

  • Mark Lomax

  • Jo Woodward

  • Sanjeeva Dissanayake

  • Tim Overend

Medical Centers

  • BioKinetic Europe Limited, Belfast, United Kingdom

  • Mundipharma Research Limited, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Fluticasone propionate

  • Fluticasone furoate

  • Formoterol

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

  • Open Label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved